Thematic Snapshot – Antibody Drug Conjugates (ADCs) Biotech M&A has been an intriguing area recently, as outlined in the Quarterly Brief, and one potential deal...
ZymeWorks (ZYME) notable insider on 1/27 from director Troy Cox of 7,500 shares at $46.50, a nearly $350,000 investment. This is the first open market buy...